Portfolio Category: Clinical Trial Experience

The exact cause of Barrett’s esophagus is not fully understood, but long-term GERD is the number one risk factor. Not all people with GERD get Barrett’s esophagus – in fact, it develops in less than 10% of people with GERD. It is more common in people who have had GERD for a long time or who were diagnosed with it at a young age.

Learn more about clinical trials for the diagnosis and treatment of Barrett’s Esophagus.

LUCID DIAGNOSTICS PROTOCOL PR-0139 (EG-CL-101) A Multicenter, Single-Arm Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck versus Esophagogastroduodenoscopy for the Diagnosis of Barrett’s Esophagus in an At-Risk Screening Population

LUCID DIAGNOSTICS PROTOCOL PR-0138 (EG-CL-102) A Multicenter Case-Control Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck, versus Esophagogastroduodenoscopy, for the Diagnosis of Barrett’s Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma

Contact Research

Clinical trials look at new ways to prevent, detect or treat gastrointestinal diseases or conditions, while also providing valuable information about health and disease progress. Colonoscopy is the most important step in the prevention of colon cancer. Colonoscopy is the only colon cancer screening method that allows your gastroenterologist to visualize the entire colon and remove most polyps at the same time.

The most important step prior to your colonoscopy is cleaning out your colon. This will allow your physician to discover and remove polyps. Learn more about a new trial on colonoscopy prep.

Contact Research

Eosinophilic Gastroenteritis/Duodenitis

---

Eosinophilic Gastroenteritis/Duodenitis is a rare disease in which a type of white blood cell, the eosinophil, causes injury and inflammation to the stomach and the small intestine. Eosinophilic gastroenteritis may affect both adults and children. The cause is unknown.

Symptoms:

• Vomiting, nausea, diarrhea
• Difficulty feeding and/or gaining weight
• Poor growth and weight loss
• Abdominal pain
• Bloody diarrhea
• Malnutrition
• Fatigue

Current Clinical Trials

---

ClinicalTrials.gov Study Details
Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) (ENIGMA 2)
Clinical Research Protocol AK002-016 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) Who Have an Inadequate Response with, Lost Response to, or Were Intolerant to Standard Therapies

Clinical Research Protocol AK002-019 A Prospective Study to Identify the Prevalence of Eosinophilic Gastrointestinal Diseases and Elevated Tissue Mast Cells among Patients with Chronic Gastrointestinal Symptoms

Dr. Lankarani reviews the link between Eosinophilic Gastroenteritis and IBS.

https://vimeo.com/391591255 Contact Research